Central to Neucin Design’s continued commitment to innovation in the medical device space, is our drive to establish drug delivery device platforms through internal innovation, research and development activities.
Neucin Design’s approach is driven by the exploration and adoption of technologies in order to recognise development prospects and exploit unique and strategic opportunities for both established and emerging markets
As a result Neucin Design’s UAT MDS (Microdroplet Delivery System) was born which can encompass a variety of delivery cores, each with a unique drug delivery pathway configuration and capability.
Each delivery core utilises an ultrasonic nebuliser technology platform which is capable of aerosolizing a range of medical and commercially available liquid formulations and can be coupled with a series of device variants to meet the needs of specific market and use-case requirements.